Top

Published in:

01-06-2015 | Research Article

TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF

Authors: Allan C. Calsavara, Frederico M. Soriani, Leda Q. Vieira, Priscila A. Costa, Milene A. Rachid, Antônio L. Teixiera

Published in: Metabolic Brain Disease | Issue 3/2015

Abstract

The involvement of TNF-α type 1 receptor (TNFR1) in memory deficits induced by sepsis was explored by using TNFR1 knockout (KO) mice. We reported that wild type (WT) mice presented memory deficits in the novel object recognition test 10 days after sepsis induced by cecum ligation and perforation (CLP). These deficits were not observed in TNFR1 KO mice. The involvement of serum and brain cytokines TNF-α, IL-1β, IL-6, IFN-γ and IL-10 was then investigated. TNFR1 KO mice had higher serum levels of TNF-α and IL-1β, and brain levels of TNF-α than WT mice. After CLP, the brain levels of TNF-α, IL-1β, IL-6 and IFN-γ increased in both WT and KO mice. Our next step was to determine the expression of inflammatory cytokines, BDNF and TrKb in the hippocampus. The absence of TNFR1 in mice subjected to polymicrobial sepsis resulted in higher BDNF expression in the hippocampus. In conclusion, after CLP, memory is preserved in the absence of TNFR1. This finding was associated with increased BDNF expression in the hippocampus.

Alvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M (2007) Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging 28:533–536. doi:10.1016/j.neurobiolaging.2006.02.012 CrossRefPubMed

Baune BT, Wiede F, Braun A, Golledge J, Arolt V, Koerner H (2008) Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet 147B:1056–1064. doi:10.1002/ajmg.b.30712 CrossRefPubMed

Baune BT, Camara ML, Eyre H, Jawahar C, Anscomb H, Korner H (2012) Tumor necrosis factor-alpha mediated mechanisms of cognitive dysfunction. Transl Neurosci 3:263–277. doi:10.2478/s13380-012-0027-8 CrossRef

Bronner MB, Knoester H, Sol JJ, Bos AP, Heymans HS, Grootenhuis MA (2009) An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock. Pediatr Crit Care Med 10:636–642. doi:10.1097/PCC.0b013e3181ae5c1a CrossRefPubMed

Calsavara AC et al (2013) Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis. Neurotox Res 24:103–108. doi:10.1007/s12640-012-9364-1 CrossRefPubMed

Camara ML, Corrigan F, Jaehne EJ, Jawahar MC, Anscomb H, Koerner H, Baune BT (2013) TNF-alpha and its receptors modulate complex behaviours and neurotrophins in transgenic mice. Psychoneuroendocrinology 38:3102–3114. doi:10.1016/j.psyneuen.2013.09.010 CrossRefPubMed

Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18–21. doi:10.1016/j.coph.2006.08.009 CrossRefPubMed

Chavan SS et al (2012) HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med 18:930–937PubMedCentralPubMed

Clark IA, Alleva LM, Vissel B (2010) The roles of TNF in brain dysfunction and disease. Pharmacol Ther 128:519–548. doi:10.1016/j.pharmthera.2010.08.007 CrossRefPubMed

Comim CM et al (2011) Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med 37:711–718. doi:10.1007/s00134-011-2151-2 CrossRefPubMed

Dellinger RP et al (2013a) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228. doi:10.1007/s00134-012-2769-8 CrossRefPubMed

Dellinger RP et al (2013b) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637. doi:10.1097/CCM.0b013e31827e83af CrossRefPubMed

Doi K, Leelahavanichkul A, Yuen PS, Star RA (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119:2868–2878. doi:10.1172/JCI3942139421 CrossRefPubMedCentralPubMed

Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47–59. doi:10.1016/0166-4328(88)90157-X CrossRefPubMed

Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G (1991) Elevated circulating tumor necrosis factor levels in Alzheimer’s disease. Neurosci Lett 129:318–320CrossRefPubMed

Hildebrand F, Pape HC, Harwood P, Wittwer T, Krettek C, van Griensven M (2004) Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-alpha receptor (TNF-RI)? A study in TNF-RI (TNF-RI(-/-)) knock-out rodents. Clin Exp Immunol 138:221–229CrossRefPubMedCentralPubMed

Hopkins RO, Weaver LK, Chan KJ, Orme JF Jr (2004) Quality of life, emotional, and cognitive function following acute respiratory distress syndrome. J Int Neuropsychol Soc 10:1005–1017PubMed

Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH (2005) Cecal ligation and puncture. Shock 24(Suppl 1):52–57

Imamura Y, Wang H, Matsumoto N, Muroya T, Shimazaki J, Ogura H, Shimazu T (2011) Interleukin-1beta causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience 187:63–69. doi:10.1016/j.neuroscience.2011.04.063 CrossRefPubMed

Iwashyna TJ, Ely EW, Smith DM, Langa KM (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787–1794. doi:10.1001/jama.2010.1553 CrossRefPubMedCentralPubMed

Jackson JC, Mitchell N, Hopkins RO (2011) Cognitive functioning, mental health, and quality of life in ICU survivors: an overview. Anesthesiol Clin 29:751–764CrossRefPubMed

Lu B, Nagappan G, Guan X, Nathan PJ, Wren P (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14:401–416. doi:10.1038/nrn3505 CrossRefPubMed

Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor-necrosis-factor-alpha (Tnf-Alpha) increases both in the brain and in the cerebrospinal-fluid from Parkinsonian-patients. Neurosci Lett 165:208–210. doi:10.1016/0304-3940(94)90746-3 CrossRefPubMed

Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson’s disease. Adv Res Neurodegener 8:277–290CrossRef

Paganelli R et al (2002) Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer’s disease patients. Exp Gerontol 37:257–263. doi:10.1016/S0531-5565(01)00191-7 CrossRefPubMed

Peng SY, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. J Neurochem 93:1412–1421. doi:10.1111/j.1471-4159.2005.03135.x CrossRefPubMed

Rocha NP et al (2014) Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson’s disease. Mov Disord 29:527–531. doi:10.1002/mds.25752 CrossRefPubMed

Rothenhausler HB, Ehrentraut S, Stoll C, Schelling G, Kapfhammer HP (2001) The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study. Gen Hosp Psychiatry 23:90–96CrossRefPubMed

Saha RN, Liu XJ, Pahan K (2006) Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharm 1:212–222. doi:10.1007/s11481-006-9020-8 CrossRef

Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD (2000) Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35–55)-induced experimental autoimmune encephalomyelitis. Cell Immunol 205:24–33CrossRefPubMed

Takata F et al (2011) Brain pericytes among cells constituting the blood–brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation 8:106CrossRefPubMedCentralPubMed

Tarkowski E, Blennow K, Wallin A, Tarkowski A (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19:223–230CrossRefPubMed

Teixeira AL, Barbosa IG, Diniz BS, Kummer A (2010) Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med 4:871–887. doi:10.2217/bmm.10.111 CrossRefPubMed

Tuon L, Comim CM, Petronilho F, Barichello T, Izquierdo I, Quevedo J, Dal-Pizzol F (2008) Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med 34:1724–1731. doi:10.1007/s00134-008-1129-1 CrossRefPubMed

Waters JP, Pober JS, Bradley JR (2013) Tumour necrosis factor in infectious disease. J Pathol 230:132–147. doi:10.1002/path.4187 CrossRefPubMed

Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock—a review of laboratory models and a proposal. J Surg Res 29:189–201. doi:10.1016/0022-4804(80)90037-2 CrossRefPubMed

Zampieri FG, Park M, Machado FS, Azevedo LC (2011) Sepsis-associated encephalopathy: not just delirium. Clinics (Sao Paulo) 66:1825–1831CrossRef

Title: TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF
Authors: Allan C. Calsavara
Frederico M. Soriani
Leda Q. Vieira
Priscila A. Costa
Milene A. Rachid
Antônio L. Teixiera
Publication date: 01-06-2015
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3/2015
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-014-9610-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Erratum to: TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF

Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice

Induction of DJ-1 protects neuronal cells from isoflurane induced neurotoxicity

Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay

Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats

Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia